TYK Medicines, Inc (HKG:2410)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Developing and Commercialising Pharmaceutical Products	107.00K	-	44.24M
Total	107.00K	-	44.24M

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
China	107.00K	-	44.24M
Total	107.00K	-	44.24M

Data Source: S&P Global Market Intelligence Last updated: Sep 11, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 8, 2026

Data Sources Report a data error